mTOR inhibitors may benefit kidney transplant recipients with mitochondrial diseases

Mitochondrial diseases represent a significant clinical challenge. Substantial efforts have been devoted to identifying therapeutic strategies for mitochondrial disorders, but effective interventions have remained elusive. Recently, we reported attenuation of disease in a mouse model of the human mi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Kidney Int
Main Authors: Johnson, Simon C., Martinez, Frank, Bitto, Alessandro, Gonzalez, Brenda, Tazaerslan, Cagdas, Cohen, Camille, Delaval, Laure, Timsit, José, Knebelmann, Bertrand, Terzi, Fabiola, Mahal, Tarika, Zhu, Yizhou, Morgan, Philip G., Sedensky, Margaret M., Kaeberlein, Matt, Legendre, Christophe, Suh, Yousin, Canaud, Guillaume
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6389356/
https://ncbi.nlm.nih.gov/pubmed/30471880
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.kint.2018.08.038
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados